Home Cart Sign in  
Chemical Structure| 200933-14-8 Chemical Structure| 200933-14-8

Structure of m-3M3FBS
CAS No.: 200933-14-8

Chemical Structure| 200933-14-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

m-3M3FBS is a novel phospholipase C activator. It can be developed as a novel anti-leukemic agent.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of m-3M3FBS

CAS No. :200933-14-8
Formula : C16H16F3NO2S
M.W : 343.36
SMILES Code : O=S(C1=C(C)C=C(C)C=C1C)(NC2=CC=CC(C(F)(F)F)=C2)=O
MDL No. :MFCD00095824
InChI Key :ZIIUUSVHCHPIQD-UHFFFAOYSA-N
Pubchem ID :761523

Safety of m-3M3FBS

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

Description
m-3M3FBS acts as a potent activator of phospholipase C (PLC), enhancing superoxide production in human neutrophils, increasing intracellular calcium levels, and promoting inositol phosphate generation across various cell lines, leading to apoptosis in monocytic leukemia cells[1].[2].[3].

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse peritoneal macrophages 10 mM 30 minutes inhibited TAK1 phosphorylation and activation of the MAPKs and NF-κB pathways Nat Commun. 2019 Feb 14;10(1):746
HCT 116 cells 25 μM Induced intracellular Ca2+ release, leading to mitochondrial inner membrane permeabilization (MIMP) and cell death Cell Death Differ. 2022 Jul;29(7):1318-1334
HeLa cells 25 μM approx. 200–400 s Induced intracellular Ca2+ release, leading to mitochondrial inner membrane permeabilization (MIMP) and cell death Cell Death Differ. 2022 Jul;29(7):1318-1334
rat hippocampal CA1 pyramidal cells 30 μM 60 seconds restore PLCβ-dependent S-eCB mobilization disrupted by AβO Alzheimers Res Ther. 2021 Oct 8;13(1):165
CHO cells (Chinese hamster ovary cells) 25 μM m-3M3FBS caused a slowly developing Ca2+ elevation, though of lower magnitude than in SH-SY5Y cells. No inositol phosphate elevation was observed after 20 minutes of stimulation. Br J Pharmacol. 2004 Sep;143(1):3-7
SH-SY5Y human neuroblastoma cells 25 μM 4-6 minutes m-3M3FBS caused a slowly developing Ca2+ elevation, indicating Ca2+ release from intracellular stores such as endoplasmic reticulum and mitochondria. No PLC activation was detected within the time frame of Ca2+ elevation (up to 7 minutes). Br J Pharmacol. 2004 Sep;143(1):3-7
mouse ventricular myocytes 25 μM m-3M3FBS (a putative PLC activator) suppressed the activation of VRAC current, and this effect was reversed by intracellular excess PIP2 Br J Pharmacol. 2010 Sep;161(1):193-206
Aplysia bag cell neurons 25 μM 20 min Activation of PLC, mimicking DAG release, induces inward current J Physiol. 2016 Oct 1;594(19):5573-92
WEHI-231 cells 50 μM Activated PLC, thereby activating LK bg channels J Physiol. 2007 Aug 1;582(Pt 3):977-90
platelets 100, 200, 400 μM m-3M3FBS, as a direct PLC activator, dose-dependently activated platelet PLCγ2 and induced platelet aggregation. Fc pretreatment partially restored m-3M3FBS-induced platelet aggregation. Front Pharmacol. 2018 Nov 6;9:1293
T-REx-TRPM3 cells 5 μM 3 hours preincubation, 24 hours stimulation Test the effect of m-3M3FBS on TRPM3 signaling, results showed nearly 98% inhibition of TRPM3 signaling Int J Mol Sci. 2022 Aug 24;23(17):9590
HEK293-M8 cells 5 μM 3 hours preincubation, 24 hours stimulation Test the effect of m-3M3FBS on TRPM8 signaling, results showed nearly 90% inhibition of TRPM8 signaling Int J Mol Sci. 2022 Aug 24;23(17):9590
HEK293 cells 1 μM 24 hours Test the effect of m-3M3FBS on AP-1 activity, results showed 1 μM concentration marginally activated AP-1 activity Int J Mol Sci. 2022 Aug 24;23(17):9590

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Plcb2 knockout mice Intraperitoneal injection 5 mg/kg Three times (1 day before, 2 days after, and 5 days after infection) Alleviated CVA16 infection-induced histopathology and prolonged survival Nat Commun. 2019 Feb 14;10(1):746
5XFAD mice Alzheimer's disease model Direct hippocampal injection 50 μM Single injection, 3-day recovery Restore hippocampus-dependent contextual fear memory Alzheimers Res Ther. 2021 Oct 8;13(1):165
Least shrew (Cryptotis parva) Model of vomiting Intraperitoneal (i.p.) 50 mg/kg Single dose, observed for 2 hours To investigate the emetic potential of m-3M3FBS in the least shrew model of vomiting. It was found that a 50 mg/kg dose induced vomiting in ~90% of tested shrews, accompanied by significant increases in c-Fos expression and ERK1/2 phosphorylation in the brainstem dorsal vagal complex. Front Pharmacol. 2021 Sep 10;12:736842

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.91mL

0.58mL

0.29mL

14.56mL

2.91mL

1.46mL

29.12mL

5.82mL

2.91mL

References

 

Historical Records

Categories